MRKR - Marker Therapeutics, Inc.

QQQ $ 467.79 $ -0.84 (-0.18 %)

DIA $ 410.88 $ 1.42 (0.35 %)

SPY $ 555.11 $ 0.12 (0.02 %)

TLT $ 100.28 $ -0.09 (-0.09 %)

GLD $ 234.69 $ 0.05 (0.02 %)

Previous Close

$ 2.78

Open

Bid

-- x --

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 2.40 - $ 6.30

Volume

84,110

Average Volume

Market Cap

24.81M

Beta (5Y Monthly)

$ 1.00

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-14-2024	06-30-2024	10-Q
2	05-15-2024	03-31-2024	10-Q
3	03-25-2024	12-31-2023	10-K
4	11-09-2023	09-30-2023	10-Q
5	08-14-2023	06-30-2023	10-Q
6	05-15-2023	03-31-2023	10-Q
7	03-22-2023	12-31-2022	10-K
8	11-10-2022	09-30-2022	10-Q
9	08-11-2022	06-30-2022	10-Q
10	05-12-2022	03-31-2022	10-Q
11	03-17-2022	12-31-2021	10-K
12	11-10-2021	09-30-2021	10-Q
13	08-10-2021	06-30-2021	10-Q
14	05-12-2021	03-31-2021	10-Q
15	03-09-2021	12-31-2020	10-K
16	11-09-2020	09-30-2020	10-Q
17	08-10-2020	06-30-2020	10-Q
18	05-11-2020	03-31-2020	10-Q
19	03-12-2020	12-31-2019	10-K
20	11-12-2019	09-30-2019	10-Q
21	08-09-2019	06-30-2019	10-Q
22	05-10-2019	03-31-2019	10-Q
23	03-15-2019	12-31-2018	10-K
24	11-13-2018	09-30-2018	10-Q
25	08-09-2018	06-30-2018	10-Q
26	05-15-2018	03-31-2018	10-Q
27	03-23-2018	12-31-2017	10-K
28	11-14-2017	09-30-2017	10-Q
29	08-07-2017	06-30-2017	10-Q
30	05-05-2017	03-31-2017	10-Q
31	03-14-2017	12-31-2016	10-K
32	11-04-2016	09-30-2016	10-Q
33	08-15-2016	06-30-2016	10-Q
34	05-16-2016	03-31-2016	10-Q
35	04-14-2016	12-31-2015	10-K
36	11-16-2015	10-30-2015	10-Q
37	08-14-2015	06-30-2015	10-Q
38	05-15-2015	03-31-2015	10-Q
39	04-15-2015	12-31-2014	10-K
40	11-19-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Marker Therapeutics Q2 2024 GAAP EPS $(0.2...
08/14/2024 21:00:51

Marker Therapeutics (NASDAQ:MRKR) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $...

NIH Awards Marker Therapeutics $2M for Cli...
08/12/2024 11:03:06

Marker Therapeutics, Inc. (NASDAQ:MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell...

12-health-care-stocks-moving-in-wednesdays-pre-market-session

12 Health Care Stocks Moving In Wednesday'...
06/05/2024 12:06:43

Marker Therapeutics Q1 EPS $(0.27) Up From...
05/15/2024 21:24:43

Marker Therapeutics (NASDAQ:MRKR) reported quarterly losses of $(0.27) per share. This is a 52.63 percent increase over losses ...

Ladenburg Thalmann Initiates Coverage On M...
04/30/2024 14:03:42

Ladenburg Thalmann analyst Aydin Huseynov initiates coverage on Marker Therapeutics (NASDAQ:MRKR) with a Buy rating and anno...

Marker Therapeutics Reports 2023 Net Loss ...
03/25/2024 21:56:13

At December 31, 2023, Marker had cash and cash equivalents of $15.1 million. The Company believes that its existing cash and ca...

Marker Therapeutics Receives Approval from...
01/22/2024 12:46:16

cancer-cell-therapy-focused-marker-therapeutics-announces-pipeline-prioritization

Cancer Cell Therapy Focused Marker Therape...
01/08/2024 12:31:07

Marker Therapeutics Inc (NASDAQ: MRKR) announced it is restructuring its clinical programs and strategic prioritization of its ...

Marker Therapeutics Says 'MultiTAA-specifi...
01/08/2024 12:30:11

Marker Therapeutics Says 'Strategic priori...
01/08/2024 12:30:04

Marker Therapeutics Announces Clinical Pro...
01/08/2024 12:29:56

12-health-care-stocks-moving-in-fridays-after-market-session

12 Health Care Stocks Moving In Friday's A...
12/29/2023 21:31:10

12-health-care-stocks-moving-in-mondays-intraday-session

12 Health Care Stocks Moving In Monday's I...
12/11/2023 17:30:56

Marker Therapeutics Announces Sustained Co...
12/11/2023 12:04:24

Marker Therapeutics, Inc. (NASDAQ:MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell...

Marker Therapeutics Q3 EPS $(0.34) Up From...
11/10/2023 00:03:53

Marker Therapeutics (NASDAQ:MRKR) reported quarterly losses of $(0.34) per share. This is a 57.5 percent increase over losses o...

why-is-blood-cancer-focused-marker-therapeutics-stock-trading-higher-today

Why Is Blood Cancer Focused Marker Therape...
09/11/2023 17:46:27

Marker Therapeutics Inc (NASDAQ: MRKR) released the preliminary results of the first participant treated with MT-601, its multi...

why-avantax-shares-are-trading-higher-by-over-27-here-are-other-stocks-moving-in-mondays-mid-day-session

Why Avantax Shares Are Trading Higher By O...
09/11/2023 17:38:46

Gainers Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) jumped 76% to $28.13 after the company's once-daily oral paltuso...

Marker Therapeutics Announced The Prelimin...
09/11/2023 11:04:51

Marker Therapeutics Q2 EPS $0.29 Up From $...
08/14/2023 20:57:04

Marker Therapeutics (NASDAQ:MRKR) reported quarterly earnings of $0.29 per share. This is a 126.36 percent increase over losses...

Marker Therapeutics Announced Non-clinical...
08/07/2023 11:36:47